0001640147-20-000007.txt : 20200707 0001640147-20-000007.hdr.sgml : 20200707 20200707190520 ACCESSION NUMBER: 0001640147-20-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200702 FILED AS OF DATE: 20200707 DATE AS OF CHANGE: 20200707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EHRLICH JASON CENTRAL INDEX KEY: 0001754049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38682 FILM NUMBER: 201016943 MAIL ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kodiak Sciences Inc. CENTRAL INDEX KEY: 0001468748 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270476525 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 650-281-0850 MAIL ADDRESS: STREET 1: 2631 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: Oligasis, LLC DATE OF NAME CHANGE: 20090721 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-07-02 0 0001468748 Kodiak Sciences Inc. KOD 0001754049 EHRLICH JASON 2631 HANOVER STREET PALO ALTO CA 94304 0 1 0 0 See Remarks Common Stock 2020-07-02 4 M 0 2700 10.29 A 33984 D Stock Option (Right to Buy) 10.29 2020-07-02 4 M 0 2700 0 A 2028-08-29 Common Stock 2700 393425 D Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Chief Medical Officer and Chief Development Officer /s/ Carlton Fleming, Attorney-in-Fact for Jason Ehrlich 2020-07-07